The Pharmacy Compounding Advisory Committee met to evaluate seven restricted peptides for specific uses:2 BPC-157 for ulcerative colitis TB-500 for wound-healing KPV for wound-healing and inflammation MOTS-c for obesity and osteoporosis Epitalon for insomnia Semax for cerebral ischemia, migraine, and trigeminal neuralgia Emideltide (DSIP) for opioid withdrawal, chronic insomnia, and narcolepsy The committee voted in favor of lifting restrictions on only the first six
BPC 157 and Musculoskeletal Recovery and Collagen Synthesis in Lab Settings
Cyanocobalamin is the most widely available synthetic form, is shelf-stable, and is FDA-approved for treating B12 deficiency
Its experimental effects reflect combined actions on vascular regulation, inflammatory balance, cellular protection, and structural remodeling, collectively supporting tissue adaptation and recovery under stress conditions
Lot Traceability Each vial carries a unique lot number linked to its full analytical record